Impaired Control of Epstein Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease

被引:22
作者
Arjunaraja, Swadhinya [1 ]
Angelus, Pamela [2 ,3 ]
Su, Helen C. [2 ]
Snow, Andrew L. [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA
[2] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Leidos Biomed Res Inc, Natl Canc Inst Frederick, Clin Res Directorate, Clin Monitoring Res Program, Frederick, MD USA
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
基金
美国国家卫生研究院;
关键词
Epstein-Barr virus; B-cell expansion with NF-kappa B and 1-cell anergy; CARD11; NF-kappa B; primary immune deficiency; NATURAL-KILLER-CELLS; LINKED LYMPHOPROLIFERATIVE DISEASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; INHERITED CD70 DEFICIENCY; OF-FUNCTION MUTATIONS; PRIMARY IMMUNODEFICIENCIES; REPRESSIVE ELEMENTS; INHIBITORY DOMAIN; CARD11; MUTATIONS; EBV INFECTION;
D O I
10.3389/fimmu.2018.00198
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B-cell expansion with NF-kappa B and T-cell anergy (BENTA) disease is a B-cell-specific lymphoproliferative disorder caused by germline gain-of-function mutations in CARD11 These mutations force the CARD11 scaffold into an open conformation capable of stimulating constitutive NF-kappa B activation in lymphocytes, without requiring antigen receptor engagement. Many BENTA patients also suffer from recurrent infections, with 7 out of 16 patients exhibiting chronic, low-grade Epstein Barr virus (EBV) viremia. In this mini-review, we discuss EBV infection in the pathogenesis and clinical management of BENTA disease, and speculate on mechanisms that could explain inadequate control of viral infection in BENTA patients.
引用
收藏
页数:8
相关论文
共 80 条
  • [1] Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency
    Abolhassani, Hassan
    Edwards, Emily S. J.
    Ikinciogullari, Aydan
    Jing, Huie
    Borte, Stephan
    Buggert, Marcus
    Du, Likun
    Matsuda-Lennikov, Mami
    Romano, Rosa
    Caridha, Rozina
    Bade, Sangeeta
    Zhang, Yu
    Frederiksen, Juliet
    Fang, Mingyan
    Bal, Sevgi Kostel
    Haskologlu, Sule
    Dogu, Figen
    Tacyildiz, Nurdan
    Matthews, Helen F.
    McElwee, Joshua J.
    Gostick, Emma
    Price, David A.
    Palendira, Umaimainthan
    Aghamohammadi, Asghar
    Boisson, Bertrand
    Rezaei, Nima
    Karlsson, Annika C.
    Lenardo, Michael J.
    Casanova, Jean-Laurent
    Hammarstrom, Lennart
    Tangye, Stuart G.
    Su, Helen C.
    Pan-Hammarstrom, Qiang
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (01) : 91 - 106
  • [2] Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency
    Alkhairy, Omar K.
    Perez-Becker, Ruy
    Driessen, Gertjan J.
    Abolhassani, Hassan
    van Montfrans, Joris
    Borte, Stephan
    Choo, Sharon
    Wang, Ning
    Tesselaar, Kiki
    Fang, Mingyan
    Bienemann, Kirsten
    Boztug, Kaan
    Daneva, Ana
    Mechinaud, Francoise
    Wiesel, Thomas
    Becker, Christian
    Duckers, Gregor
    Siepermann, Kathrin
    van Zelm, Menno C.
    Rezaei, Nima
    van der Burg, Mirjam
    Aghamohammadi, Asghar
    Seidel, Markus G.
    Niehues, Tim
    Hammarstrom, Lennart
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (03) : 703 - +
  • [3] Characterization of the CD4+T cell response Epstein-Barr virus during primary and persistent infection
    Amyes, E
    Hatton, C
    Montamat-Sicotte, D
    Gudgeon, N
    Rickinson, AB
    McMichael, AJ
    Callan, MFC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (06) : 903 - 911
  • [4] Intrinsic Plasma Cell Differentiation Defects in B Cell Expansion with NF-κB and T Cell Anergy Patient B Cells
    Arjunaraja, Swadhinya
    Nose, Brent D.
    Sukumar, Gauthaman
    Lott, Nathaniel M.
    Dalgard, Clifton L.
    Snow, Andrew L.
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [5] Gain-of-function mutations and immunodeficiency: at a loss for proper tuning of lymphocyte signaling
    Arjunaraja, Swadhinya
    Snow, Andrew L.
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 15 (06) : 533 - 538
  • [6] Role for early-differentiated natural killer cells in infectious mononucleosis
    Azzi, Tarik
    Luenemann, Anna
    Murer, Anita
    Ueda, Seigo
    Beziat, Vivien
    Malmberg, Karl-Johan
    Staubli, Georg
    Gysin, Claudine
    Berger, Christoph
    Muenz, Christian
    Chijioke, Obinna
    Nadal, David
    [J]. BLOOD, 2014, 124 (16) : 2533 - 2543
  • [7] The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition
    Bardet, Maureen
    Unterreiner, Adeline
    Malinverni, Claire
    Lafossas, Frederique
    Vedrine, Corinne
    Boesch, Danielle
    Kolb, Yeter
    Kaiser, Daniel
    Gluck, Anton
    Schneider, Martin A.
    Katopodis, Andreas
    Renatus, Martin
    Simic, Oliver
    Schlapbach, Achim
    Quancard, Jean
    Regnier, Catherine H.
    Bold, Guido
    Pissot-Soldermann, Carole
    Carballido, Jose M.
    Kovarik, Jiri
    Calzascia, Thomas
    Bornancin, Frederic
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (01) : 81 - 99
  • [8] CARMA1-mediated NF-κB and JNK activation in lymphocytes
    Blonska, Marzenna
    Lin, Xin
    [J]. IMMUNOLOGICAL REVIEWS, 2009, 228 : 199 - 211
  • [9] CD27 and CD70 in T cell and B cell activation
    Borst, J
    Hendriks, J
    Xiao, YL
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (03) : 275 - 281
  • [10] GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease
    Bottino, C
    Falco, M
    Parolini, S
    Marcenaro, E
    Augugliaro, R
    Sivori, S
    Landi, E
    Biassoni, R
    Notarangelo, LD
    Moretta, L
    Moretta, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) : 235 - 246